September 2025
1. TAYLOR L
   Almost $10m of "incinerated" US aid contraceptives found safe, but still at risk.
   BMJ. 2025;390:r1951.
   

   >> Share

   
   August 2025
2. BOWIE K
   France pressured to stop US plan to destroy almost $10m of aid funded contraceptives.
   BMJ. 2025;390:r1631.
   

   >> Share

   
   July 2025
3. SCHUMMERS L, Cheng L, Odendaal M, Rodriguez-Llorian E, et al
   Effect of universal no-cost coverage on use of long-acting reversible contraception and all prescription contraception: population based, controlled, interrupted time series analysis.
   BMJ. 2025;390:e083874.
   

   >> Share

   
   June 2025
4. ROLAND N, Kolla E, Baricault B, Dayani P, et al
   Oral contraceptives with progestogens desogestrel or levonorgestrel and risk of intracranial meningioma: national case-control study.
   BMJ. 2025;389:e083981.
   

   >> Share

   
   
5. O'DOWD A
   Weight loss drugs could make oral contraception less effective, MHRA warns.
   BMJ. 2025;389:r1169.
   

   >> Share

   
   April 2025
6. TAYLOR L
   US contraceptive guidance team is fired in new Trump cuts.
   BMJ. 2025;389:r795.
   

   >> Share

   
   February 2025
7. MEAIDI A, Yonis H
   Research on hormonal contraceptives is needed to monitor their evolving safety profile.
   BMJ. 2025;388:r341.
   

   >> Share

   
   
8. YONIS H, Lokkegaard E, Kragholm K, Granger CB, et al
   Stroke and myocardial infarction with contemporary hormonal contraception: real-world, nationwide, prospective cohort study.
   BMJ. 2025;388:e082801.
   

   >> Share

   
   
9. JOHANSSON T
   Arterial thrombosis in users of contemporary hormonal contraception.
   BMJ. 2025;388:r237.
   

   >> Share

   
   September 2024
10. WISE J
    Valproate: Men are advised to use contraception owing to risk of neurodevelopmental disorders in children.
    BMJ. 2024;386:q1957.
    

    >> Share

    
    August 2024
11. ZENG X, Cheng L, Wu S, Qian X, et al
    Optimising contraceptive services as fertility rates fall in China.
    BMJ. 2024;386:e078642.
    

    >> Share

    
    
12. IACOBUCCI G
    Medical abortion: Taking first tablet at home after 12 weeks of pregnancy is safe, study reports.
    BMJ. 2024;386:q1902.
    

    >> Share

    
    
13. MAHASE E
    Uterine fibroids: NICE recommends new treatment option for moderate to severe symptoms.
    BMJ. 2024;386:q1805.
    

    >> Share

    
    June 2024
14. TANNE JH
    Mifepristone: US Supreme Court rejects ban on abortion drug.
    BMJ. 2024;385:q1321.
    

    >> Share

    
    
15. TANNE JH
    US Republicans block bill that would have guaranteed access to contraception.
    BMJ. 2024;385:q1251.
    

    >> Share

    
    May 2024
16. TANNE JH
    US state classifies mifepristone and misoprostol as dangerous controlled substances.
    BMJ. 2024;385:q1175.
    

    >> Share

    
    
17. COOPER KG, Bhattacharya S, Daniels JP, Horne AW, et al
    Long acting progestogens versus combined oral contraceptive pill for preventing recurrence of endometriosis related pain: the PRE-EMPT pragmatic, parallel group, open label, randomised controlled trial.
    BMJ. 2024;385:e079006.
    

    >> Share

    
    March 2024
18. TANNE JH
    US Supreme Court questions legitimacy of case seeking to ban mifepristone.
    BMJ. 2024;384:q763.
    

    >> Share

    
    
19. ROLAND N, Neumann A, Hoisnard L, Duranteau L, et al
    Use of progestogens and the risk of intracranial meningioma: national case-control study.
    BMJ. 2024;384:e078078.
    

    >> Share

    
    February 2024
20. MCNEE R
    Tackling contraceptive misinformation on social media.
    BMJ. 2024;384:q472.
    

    >> Share

    
    
21. LOOI MK
    The grey area of "fertility tech" being mis-sold as contraception.
    BMJ. 2024;384:q54.
    

    >> Share

    
    December 2023
22. WAGNER B, Cleland K
    Retail demand for emergency contraception in United States following New Year holiday: time series study.
    BMJ. 2023;383:e077437.
    

    >> Share

    
    November 2023
23. LIMB M
    Pharmacy health checks and contraceptive service could save 10 million GP appointments.
    BMJ. 2023;383:p2722.
    

    >> Share

    
    September 2023
24. MEAIDI A
    Filling in the gaps in our understanding of hormonal contraception.
    BMJ. 2023;382:2043.
    

    >> Share

    
    
25. SCHMIDT M
    NSAIDs, hormonal contraception, and venous thromboembolism.
    BMJ. 2023;382:p1990.
    

    >> Share

    
    
26. MEAIDI A, Mascolo A, Sessa M, Toft-Petersen AP, et al
    Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: nationwide cohort study.
    BMJ. 2023;382:e074450.
    

    >> Share

    
    August 2023
27. TANNE JH
    US federal court upholds limits on abortion drug mifepristone.
    BMJ. 2023;382:1924.
    

    >> Share

    
    
28. TANNE JH
    Combining anti-inflammatory drug with the morning after pill boosts effectiveness, study finds.
    BMJ. 2023;382:1920.
    

    >> Share

    
    July 2023
29. TANNE JH
    FDA approves daily over-the-counter oral contraceptive with no age restrictions.
    BMJ. 2023;382:p1631.
    

    >> Share

    
    April 2023
30. TANNE JH
    US Supreme Court allows mifepristone to remain available for now.
    BMJ. 2023;381:p923.
    

    >> Share

    
    
31. MCNALLY S
    Scarlett McNally: Let's talk about contraception.
    BMJ. 2023;381:p862.
    

    >> Share

    
    
32. TANNE JH
    Mifepristone remains available in US until midnight on 19 April.
    BMJ. 2023;381:864.
    

    >> Share

    
    
33. TANNE JH
    Opposing rulings on mifepristone in US leave access to medical abortion in jeopardy.
    BMJ. 2023;381:822.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share